Immunovia AB (publ) (LON: 0G8X)
London
· Delayed Price · Currency is GBP · Price in SEK 0.489
-0.023 (-4.49%)
Jan 21, 2025, 8:07 AM BST
Immunovia AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 0.63 | 1.58 | 1.15 | 0.84 | 0.36 | 0.36 | Upgrade
|
| Revenue | 0.63 | 1.58 | 1.15 | 0.84 | 0.36 | 0.36 | Upgrade
|
| Revenue Growth (YoY) | -67.10% | 37.55% | 35.66% | 133.15% | 1.69% | 6.91% | Upgrade
|
| Cost of Revenue | - | 6.68 | 4.21 | -14.97 | -40.02 | -26.72 | Upgrade
|
| Gross Profit | 0.63 | -5.11 | -3.07 | 15.81 | 40.38 | 27.07 | Upgrade
|
| Selling, General & Admin | 85.29 | 148.3 | 162.97 | 162.09 | 165.12 | 132.9 | Upgrade
|
| Other Operating Expenses | 4.23 | 1.56 | 0.26 | 1.4 | 0.18 | 0.08 | Upgrade
|
| Operating Expenses | 104.1 | 291.58 | 188.14 | 182.55 | 175.06 | 141.42 | Upgrade
|
| Operating Income | -103.46 | -296.69 | -191.21 | -166.74 | -134.68 | -114.35 | Upgrade
|
| Interest Expense | -12.49 | -1.16 | -1.6 | -1.43 | -1.42 | -1.32 | Upgrade
|
| Interest & Investment Income | 1.29 | 2.92 | 0.75 | 0.71 | 0.58 | 0.29 | Upgrade
|
| Currency Exchange Gain (Loss) | -14.51 | -14.51 | 23.97 | 11.5 | -10.51 | 0.87 | Upgrade
|
| EBT Excluding Unusual Items | -128.63 | -309.44 | -168.09 | -155.97 | -146.03 | -114.52 | Upgrade
|
| Pretax Income | -128.63 | -309.44 | -168.09 | -155.97 | -146.03 | -114.52 | Upgrade
|
| Income Tax Expense | - | - | - | - | - | 0 | Upgrade
|
| Net Income | -128.63 | -309.44 | -168.09 | -155.97 | -146.03 | -114.52 | Upgrade
|
| Net Income to Common | -128.63 | -309.44 | -168.09 | -155.97 | -146.03 | -114.52 | Upgrade
|
| Shares Outstanding (Basic) | 55 | 39 | 23 | 23 | 21 | 20 | Upgrade
|
| Shares Outstanding (Diluted) | 55 | 39 | 23 | 23 | 21 | 20 | Upgrade
|
| Shares Change (YoY) | 81.75% | 72.02% | - | 6.05% | 9.05% | 5.52% | Upgrade
|
| EPS (Basic) | -2.35 | -7.95 | -7.43 | -6.89 | -6.84 | -5.85 | Upgrade
|
| EPS (Diluted) | -2.36 | -7.95 | -7.43 | -6.89 | -6.84 | -5.85 | Upgrade
|
| Free Cash Flow | -96.96 | -147.06 | -176.84 | -155.75 | -124.7 | -97.99 | Upgrade
|
| Free Cash Flow Per Share | -1.77 | -3.78 | -7.81 | -6.88 | -5.84 | -5.01 | Upgrade
|
| Gross Margin | 100.00% | - | -267.77% | 1873.58% | 11155.25% | 7604.49% | Upgrade
|
| Operating Margin | -16370.89% | -18837.27% | -16699.48% | -19756.04% | -37203.87% | -32120.79% | Upgrade
|
| Profit Margin | -20353.01% | -19646.92% | -14680.52% | -18479.38% | -40340.61% | -32168.82% | Upgrade
|
| Free Cash Flow Margin | -15342.25% | -9336.95% | -15444.37% | -18453.67% | -34448.07% | -27524.16% | Upgrade
|
| EBITDA | -103.95 | -170.03 | -185.15 | -161.1 | -130.41 | -110.5 | Upgrade
|
| D&A For EBITDA | -0.49 | 126.66 | 6.06 | 5.64 | 4.27 | 3.85 | Upgrade
|
| EBIT | -103.46 | -296.69 | -191.21 | -166.74 | -134.68 | -114.35 | Upgrade
|
| Revenue as Reported | 1.4 | 1.8 | 1.2 | 0.96 | 0.99 | 0.81 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.